Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478192 · ClinicalTrials.gov registry record · Phase 3
Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
A Phase 3 study, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT00478192 is a Phase 3 study that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 50 participants.
The verdict
NCT00478192, a Phase 3 study, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
The study is designed to assess the efficacy and safety of multiple infusions of conivaptan in subjects with euvolemic or hypervolemic hyponatremia
Interventions
- DRUG Placebo
- DRUG Conivaptan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00478192
The ClinicalTrials.gov registry entry for NCT00478192 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00478192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00478192 about?
NCT00478192 is a clinical study titled "Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia". The study is designed to assess the efficacy and safety of multiple infusions of conivaptan in subjects with euvolemic or hypervolemic hyponatremia
What is the current status of trial NCT00478192?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2007-04. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00478192?
The interventions under investigation include: Placebo (DRUG), Conivaptan (DRUG).
Who is sponsoring clinical trial NCT00478192?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.